4-(2-(2-((4-oxo-4-(4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)butanoyl)oxy)ethoxy)ethoxy)-3-(phenylsulfonyl)-1,2,5-oxadiazole-2-oxide

ID: ALA4540195

PubChem CID: 155550154

Max Phase: Preclinical

Molecular Formula: C36H38F3N5O9S2

Molecular Weight: 805.85

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(CCC(=O)N1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1)OCCOCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1

Standard InChI:  InChI=1S/C36H38F3N5O9S2/c37-36(38,39)26-11-12-31-29(25-26)43(28-9-4-5-10-30(28)54-31)16-6-15-41-17-19-42(20-18-41)32(45)13-14-33(46)51-23-21-50-22-24-52-34-35(44(47)53-40-34)55(48,49)27-7-2-1-3-8-27/h1-5,7-12,25H,6,13-24H2

Standard InChI Key:  LVKDEJSIGUTXER-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 55 60  0  0  0  0  0  0  0  0999 V2000
    5.8713  -19.7668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5847  -19.3517    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2982  -19.7668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2982  -20.5883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5847  -21.0034    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.8713  -20.5883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1604  -21.0009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4423  -20.5903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4398  -19.7662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1532  -19.3496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0204  -21.0055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7297  -20.5889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7272  -19.7649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0132  -19.3543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4445  -19.3543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4445  -18.5289    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.1577  -19.7649    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.1577  -18.9436    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.5847  -18.5264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3021  -18.1158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3021  -17.2904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0153  -16.8755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0153  -16.0502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7285  -15.6396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4417  -16.0503    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.4417  -16.8756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7286  -17.2904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1590  -15.6396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1590  -14.8142    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8723  -16.0503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5855  -15.6396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3029  -16.0503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0160  -15.6396    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.7293  -16.0503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4425  -15.6396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1599  -16.0503    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.8730  -15.6396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5862  -16.0503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3036  -15.6396    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.0168  -16.0503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7688  -15.7166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3203  -16.3302    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.9100  -17.0429    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.1025  -16.8727    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.1457  -16.3302    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.9825  -14.9188    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   19.7801  -14.7052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9941  -13.9117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7887  -13.6958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3730  -14.2801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1590  -15.0728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3636  -15.2928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7682  -14.1232    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.1847  -14.7052    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.3029  -16.8756    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  1  0
  1  6  2  0
  6  7  1  0
  8  7  2  0
  9  8  1  0
 10  9  2  0
  1 10  1  0
  4 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
  3 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
  2 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 23 22  1  0
 24 23  1  0
 25 24  1  0
 26 25  1  0
 27 26  1  0
 22 27  1  0
 25 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 41 40  1  0
 41 42  2  0
 42 43  1  0
 43 44  1  0
 44 40  2  0
 42 45  1  0
 41 46  1  0
 46 47  1  0
 48 47  2  0
 49 48  1  0
 50 49  2  0
 51 50  1  0
 52 51  2  0
 47 52  1  0
 46 53  2  0
 46 54  2  0
 32 55  2  0
M  CHG  2  42   1  45  -1
M  END

Alternative Forms

  1. Parent:

    ALA4540195

    ---

Associated Targets(Human)

SUM-159-PT (149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-BR-3 (5175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 805.85Molecular Weight (Monoisotopic): 805.2063AlogP: 4.72#Rotatable Bonds: 16
Polar Surface Area: 158.66Molecular Species: NEUTRALHBA: 13HBD:
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 6.82CX LogP: 3.48CX LogD: 3.37
Aromatic Rings: 4Heavy Atoms: 55QED Weighted: 0.09Np Likeness Score: -1.38

References

1. Gao Y, Sun TY, Bai WF, Bai CG..  (2019)  Design, synthesis and evaluation of novel phenothiazine derivatives as inhibitors of breast cancer stem cells.,  183  [PMID:31541872] [10.1016/j.ejmech.2019.111692]

Source